Effect of Premature Luteinization on the Oocyte Quality in Oocyte Donation Program.

Premature Luteinization Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00455949
• Other study ID #: VLC-MM-0106-307-14
• Status: Completed
• Phase: N/A
• First received: April 3, 2007
• Last updated: April 3, 2007

Study information

• Verified date: April 2007
• Source: Instituto Valenciano de Infertilidad, IVI VALENCIA
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Analyze the possible effect of the progesterone levels of the hCG administration on the oocyte embryo quality. The primary endpoint of this study is the pregnancy rate.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 34 Years

Eligibility

Inclusion Criteria:

• Oocyte donors; age range: 18 - 34; BMI: 18 - 29; long protocol.

Exclusion Criteria:

• PCO syndrome;

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Premature Birth
• Premature Luteinization

Locations

Country	Name	City	State
Spain	Instituto Valenciano de la Infertilidad	Valencia

Sponsors (1)

Lead Sponsor	Collaborator
Instituto Valenciano de Infertilidad, IVI VALENCIA

Country where clinical trial is conducted

Spain,